These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16858070

  • 1. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.
    Cantor T, Yang Z, Caraiani N, Ilamathi E.
    Clin Chem; 2006 Sep; 52(9):1771-6. PubMed ID: 16858070
    [Abstract] [Full Text] [Related]

  • 2. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H, Esser A, Roth HJ, Schmidt-Gayk H.
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [Abstract] [Full Text] [Related]

  • 3. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
    Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR.
    Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone assay drift: an unappreciated problem in dialysis patient management.
    Cantor T.
    Semin Dial; 2005 May; 18(5):359-64. PubMed ID: 16191171
    [Abstract] [Full Text] [Related]

  • 5. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
    Herberth J, Fahrleitner-Pammer A, Obermayer-Pietsch B, Krisper P, Holzer H, Malluche HH, Dobnig H.
    Clin Nephrol; 2006 May; 65(5):328-34. PubMed ID: 16724653
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients.
    Sheth RD, Goldstein SL.
    Pediatr Nephrol; 2005 Jul; 20(7):977-81. PubMed ID: 15856315
    [Abstract] [Full Text] [Related]

  • 7. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 8. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Müller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmüller T, Troch T, Bergmann P.
    Clin Lab; 2002 Jun; 48(3-4):131-41. PubMed ID: 11934215
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a new, rapid and automated immunochemiluminometric assay for the measurement of serum intact parathyroid hormone.
    Michelangeli VP, Heyma P, Colman PG, Ebeling PR.
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():97-103. PubMed ID: 9022895
    [Abstract] [Full Text] [Related]

  • 10. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.
    John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4287-90. PubMed ID: 10566687
    [Abstract] [Full Text] [Related]

  • 11. Comparison of three different immunoassay methods for the evaluation of intact parathyroid hormone levels in hemodialysis patients.
    Ates F, Koken T, Demir S, Kahraman A, Dogan N.
    Scand J Clin Lab Invest; 2011 May; 71(3):227-31. PubMed ID: 21294669
    [Abstract] [Full Text] [Related]

  • 12. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
    Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H.
    Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
    [Abstract] [Full Text] [Related]

  • 13. Inter-method variability in PTH measurement: implication for the care of CKD patients.
    Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P.
    Kidney Int; 2006 Jul; 70(2):345-50. PubMed ID: 16788691
    [Abstract] [Full Text] [Related]

  • 14. Intraoperative measurement of intact parathyroid hormone in renal hyperparathyroidism by an inexpensive routine assay.
    Seehofer D, Rayes N, Ulrich F, Müller C, Lang M, Neuhaus P, Steinmüller T.
    Langenbecks Arch Surg; 2001 Nov; 386(6):440-3. PubMed ID: 11735018
    [Abstract] [Full Text] [Related]

  • 15. Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients.
    Malluche HH, Mawad H, Trueba D, Monier-Faugere MC.
    Clin Nephrol; 2003 May; 59(5):313-8. PubMed ID: 12779091
    [Abstract] [Full Text] [Related]

  • 16. The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients.
    Herberth J, Monier-Faugere MC, Mawad HW, Branscum AJ, Herberth Z, Wang G, Cantor T, Malluche HH.
    Clin Nephrol; 2009 Jul; 72(1):5-14. PubMed ID: 19640382
    [Abstract] [Full Text] [Related]

  • 17. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M, Jean G, Bacri JL, Lemaitre V, Masy E, Joly D, Souberbielle JC.
    Clin Chem Lab Med; 2009 Jul; 47(3):362-6. PubMed ID: 19199835
    [Abstract] [Full Text] [Related]

  • 18. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
    Goodman WG.
    Blood Purif; 2003 Jul; 21(1):118-23. PubMed ID: 12596757
    [Abstract] [Full Text] [Related]

  • 19. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T, Garzoni D, Staub T, Binet I, Wüthrich RP.
    Kidney Blood Press Res; 2006 Jul; 29(3):175-81. PubMed ID: 16931896
    [Abstract] [Full Text] [Related]

  • 20. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
    Fujimori A, Sakai M, Yoshiya K, Shin J, Kim JI, Inaba Y, Miyamoto T, Inoue S, Fukagawa M.
    Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.